Placental protein 13 as an early marker for pre-eclampsia: A prospective longitudinal study

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 115, Issue 12, 2008, Pages 1465-1472

  Gonen, R ^a,c   Shahar, R ^b   Grimpel, Y I ^b   Chefetz, I ^b   Sammar, M ^b   Meiri, H ^b   Gibor, Y ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Diagnostic Technologies Ltd   (Israel)

^c BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

Placental protein 13; Pre eclampsia; Serum markers

Indexed keywords

BIOLOGICAL MARKER; PLACENTA PROTEIN; PLACENTAL PROTEIN 13; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HEALTH CENTER; HUMAN; LONGITUDINAL STUDY; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SCREENING TEST; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; SEQUENTIAL ANALYSIS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; EARLY DIAGNOSIS; FEMALE; GALECTINS; HUMANS; MIDDLE AGED; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 53849143269     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2008.01902.x     Document Type: Article

References (34)

1. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001 357 : 53 6.
2. Askie LM, Duley L, Henderson-Smart D, Stewart LA, on behalf of the PARIS Collaboration Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007 369 : 1791 8.
3. Hofmeyr GJ, Duley L, Atallah A. Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary. BJOG 2007 114 : 933 43.
4. Raty R, Koskinen P, Alanen A, Irjala K, Matilauri I, Ekblad U, et al. Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels. Prenat Diagn 1999 19 : 122 7.
5. Yaron Y, Cherry M, Kramer RL. Second trimester maternal serum screening: maternal serum α-fetoprotein, β-chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Am J Obstet Gynecol 1999 181 : 968 74.
6. Gonen R, Perez R, David M, Dar H, Merkshamer R, Sharf M. The association between unexplained second trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol 1992 80 : 83 6.
7. Aqualina J, Maplethorpe R, Ellis P, Harrington K. Correlation between second trimester maternal serum inhibin-A and human chorionic gonadotrophin for the prediction of pre-eclampsia. Placenta 2000 21 : 487 92.
8. Ashour AMN, Liberman ES, Wilkins Haug LE, Repke JT. The value of elevated second trimester beta-human chorionic gonadotropin in predicting development of preeclampsia. Am J Obstet Gynecol 1997 176 : 438 42.
9. Muttukrishna S, Knight PG, Groome NP, Redman CW, Ledger WL. Activin-A and inhibin-A as possible endocrine markers for preeclampsia. Lancet 1997 349 : 1285 8.
10. Muttukrishna S, North RA, Morris J, Schellenberg JC, Taylor RS, Asselin J, et al. Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum Reprod 2000 15 : 1640 5. Erratum in Hum Reprod 2001 16 : 2477.
11. Spencer K, Yu CKH, Cowans NJ, Otigbah C, Nicolaides KH. Prediction of pregnancy complications by first trimester maternal serum PAPP-A and free β-hCG and with second trimester uterine artery Doppler. Prenat Diagn 2005 25 : 949 53.
12. Sorensen TK, Malinow MR, Williams MA, King IB, Luthy DA. Elevated second trimester serum homocysteine levels and subsequent risk of pre-eclampsia. Gynecol Obstet Invest 1999 48 : 98 103.
13. Wolf M, Sandler L, Muñoz K, Hsu K, Ecker JL, Thadhani R. First trimester insulin resistance and subsequent preeclampsia: a prospective study. J Clin Endocrinol Metab 2002 87 : 1563 8.
14. Thadhani H, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, et al. First trimester placental growth factor and soluble Fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004 89 : 770 5.
15. Levine RJ, Manyard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk for preeclampsia. N Engl J Med 2004 350 : 672 83.
16. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating anti-angiogenic factors in preeclampsia. N Engl J Med 2006 355 : 992 1005.
17. Florio P, Imperatore A, Sanseverino F, Torricelli M, Reis FM, Lowry PJ, et al. The measurement of maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein improves the early prediction of preeclampsia. J Clin Endocrinol Metab 2004 89 : 4673 7.
18. Papageorghiou AT, Yu CKH, Cicero S, Bower S, Nicolaides KH. Second-trimester uterine artery Doppler screening in unselected populations: a review. J Matern Fetal Neonatal Med 2002 12 : 78 88.
19. Martin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2002 18 : 583 6.
20. Burger O, Pick E, Zwickel J, Klayman M, Meiri H, Slotky R, et al. Placental protein 13 (PP13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies. Placenta 2004 25 : 608 22.
21. Than NG, Pick E, Bellyei S, Szigeti A, Burger O, Berente Z, et al. Functional analyses of placental protein 13/galectin-13. Eur J Biochem 2004 271 : 1065 78.
22. Visegrady B, Than NG, Kiler F, Sumegi B, Than GN, Bohn H. Homology modeling and molecular dynamics studies of human placental tissue protein 13 (galectin-13). Protein Eng 2001 14 : 875 80.
23. Samar M, Sadan O, Fleischafab Z, Meiri H, Huppertz B, Golan A. Molecular and cellular impacts of placenta-related pathologies on PP13 in complicated premature deliveries. Am J Obstet Gynecol 2005 193 (Suppl S77.
24. Nicolaides KH, Bindra R, Turan OM, Chefetz I, Sammar M, Meiri H, et al. A novel approach to first trimester screening for early pre-eclampsia combining serum PP13 and Doppler ultrasound. Ultrasound Obstet Gynecol 2005 27 : 13 17.
25. Spencer K, Cowans NJ, Chafetz I, Tal J, Meiri H. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol 2007 29 : 128 34.
26. Chefetz I, Kuhnreich I, Sammar M, Tal Y, Gibor Y, Meiri H, et al. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 2007 197 : 35.e1 35.e7.
27. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001 20 : IX XIV.
28. Cuckle HS, Wald N. Testing using single markers. In : Wald N, Leck I, editors. Antenatal and Neonatal Screening, 2nd edn. Oxford, UK : Oxford University Press 2000. pp. 1 22.
29. Spencer K, Cowans NJ, Chefetz I, Tal J, Kuhnreich I, Meiri H. Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre-eclampsia. Prenat Diagn 2007 27 : 258 63.
30. Vainio M, Kujansuu E, Iso-Mustajärvi M, Mäenpää J. Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG 2002 109 : 161 7.
31. Chiaffarino F, Parazzini F, Paladini D, Acaia B, Ossola W, Marozio L, et al. A small randomised trial of low-dose aspirin in women at high risk of pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2004 112 : 142 4.
32. Than NG, Sumegi B, Than GN, Berente Z, Bohn H. Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of human eosinophil Charcot-Leyden crystal protein. Placenta 1999 20 : 703 10.
33. Huppertz B, Kingdom JC. Apoptosis in the trophoblast - role of apoptosis in placental morphogenesis. J Soc Gynecol Investig 2004 11 : 353 62.
34. Huppertz B. Placental villous trophoblast: the altered balance between proliferation and apoptosis triggers pre-eclampsia. J Rep Med Endocrinol 2006 3 : 103 8.